Shire Plc AbbVie issues Statement regarding a possible offer for Shire plc
Following its announcement on June 20, 2014, AbbVie is pleased to outline the compelling strategic rationale for, and background to, its proposal to the Board of Shire of £20.44 in cash and 0.7988 ordinary shares of New AbbVie for each Shire share (the "Proposal"). The Proposal represented an indicative value of £46.26[2] on May 29, 2014 (the latest practicable date before the Proposal was made). Whilst this cash and share mix is valued at £45.64[3] per share as of June 24, 2014 any firm offer made by AbbVie under Rule 2.7 of the Code will need to be equivalent to £46.26 per share (subject to the reservations set out later in this announcement). Combination has compelling strategic rationale for all shareholders
From: LAURENT CHEKROUN ()
Subject: >>> Shire Plc AbbVie issues Statement regarding a possible offer for Shire plc
Shire Plc AbbVie issues Statement regarding a possible offer for Shire plc